类风湿关节炎(RA)高危人群对知晓患病风险及接受预防性治疗的认知与体验:定性研究的系统评价与主题综合
本系统评价与主题综合纳入7项定性研究、共115例RA高危个体,识别出三大主题:对RA风险的理解、对预防性干预的认知与参与、对预测性检测的看法。多数证据为中等置信度。作者认为告知风险并提供预防治疗有益,但不确定性带来参与障碍,亟需确定最佳风险信息呈现方式以支持决策。
要点
- 7项定性研究、115例RA高危个体,识别三大主题共七个亚主题。
- 多数综述发现为中等置信度。
- 作者认为告知风险并 offer 预防治疗有益,但不确定性加剧参与障碍。
核心结论
- 作者认为,通过预测性检测告知RA高危个体其风险并提供预防性治疗有明显益处,但存在参与障碍,且因不确定性负担而加剧。
- 作者认为,亟需确定呈现风险信息(包括参与预防性干预的风险与获益)的最佳方式,以支持RA高危个体的决策。
研究设计与样本
- 系统评价与定性研究主题综合;由两名评价者独立筛选研究,使用CASP清单评价方法学质量,并采用GRADE-CERQual方法评估证据置信度。
- 共纳入7项定性研究,涉及115例RA高危个体。
主要发现
- 识别出三大主题(七个亚主题):理解罹患RA的风险(对RA的知识与潜在风险因素的识别);降低RA风险的预防性干预(对预防性干预价值与作用的理解、对预防性干预的参与);对RA预测性检测的看法(预测性检测的益处、进行预测性检测的决定、对预测性检测的担忧)。
- 多数综述发现为中等置信度。
关键数值与推荐
- PROSPERO注册号:CRD42021236034。
临床怎么用
- 作者认为,告知RA高危个体预测性检测后的风险并提供预防性治疗有明显益处,但存在参与障碍,且因不确定性负担而加剧。
- 作者认为,亟需确定呈现风险信息(包括参与预防性干预的风险与获益)的最佳方式,以支持RA高危个体的决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: There is increasing interest in identifying individuals at-risk of rheumatoid arthritis (RA) and initiating early treatment to prevent or delay the onset of arthritis. We aimed to describe the perceptions and experiences of at-risk individuals and to inform the conduct of clinical trials and studies, and clinical practice. METHODS: A systematic review and thematic synthesis of qualitative studies was conducted. Two review authors independently screened studies for inclusion, appraised their methodological quality using the Critical Appraisal Skills Programme checklist and assessed confidence in the findings using the Grading of Recommendations Assessment, Development and Evaluation-Confidence in Evidence from Reviews of Qualitative Research approach. RESULTS: Seven studies involving 115 individuals at-risk of developing RA were included. Three major themes (seven subthemes) were identified: understanding the risk of developing RA (knowledge of RA and identification of potential risk factors); preventive interventions to reduce the risk of developing RA (understanding the value and role of preventive interventions, and engagement with preventive interventions); and perceptions of predictive testing for RA (benefits of predictive testing, decision to undertake predictive testing and concerns about predictive testing). Moderate confidence in most review findings was evident. CONCLUSION: While there are clear benefits in informing individuals at-risk of RA about their risk following predictive testing and offering preventive treatment, there are potential barriers to engagement, intensified by the burden of uncertainty. Identification of the optimum approaches for presenting risk information, including the risks and benefits of engaging with preventive interventions, is urgently needed to support individuals at-risk of RA in their decision making. PROSPERO REGISTRATION NUMBER: CRD42021236034.
引用
- Siddle HJ, Chapman LS, Mankia K, et al. Perceptions and experiences of individuals at-risk of rheumatoid arthritis (RA) knowing about their risk of developing RA and being offered preventive treatment: systematic review and thematic synthesis of qualitative studies. Ann Rheum Dis. 2021. PMID: 34750103. doi:10.1136/annrheumdis-2021-221160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。